Artículos del autor

solaci

Coronary disease

Important Study Detects Radiation-Induced DNA Damage in Operators After an Endovascular Procedure

In recent years, we have seen (both as witnesses and actors) an exponential increase in the number...
solaci -
Antithrombotic Anticoagulants

The End of Aspirin for Anticoagulated Patients Undergoing PCI

The discussion about the best anti-thrombotic strategy for patients with atrial fibrillation undergoing PCI seemed never-ending until the RE-DUAL...
solaci -
Chronic Ischemic cardiopathy

TCT 2017 | FAME 2 at 3 Years: Better Results with Angioplasty and at a Cost Similar to Medical Treatment

Courtesy of SBHCI. Angioplasty in patients with chronic stable angina and functionally significant lesions improves clinical outcomes and...
solaci -
Chronic Ischemic cardiopathy

TCT 2017 | ORBITA: The Placebo Effect of Angioplasty

Courtesy of the SBHCI. Chronic stable angina and severe coronary lesion patients who undergo angioplasty in a single...
solaci -
Other

TCT 2017 | PREVAIL: Final Outcomes of the Watchman Device

Courtesy of SBHCI. The final 5-year outcomes of the PROTECT AF and PREVAIL studies (which assessed the left...
solaci -
SOLACI

TCT 2017 | The TRI-REPAIR and the FORMA Trials: New Devices for the “Forgotten Valve”

Courtesy of SBHCI. Two new transcatheter treatments for severe or massive functional tricuspid regurgitation have showed good results...
solaci -
Antiplatelet

TCT 2017 | SENIOR: DES with a Bioresorbable Polymer and Short Dual Antiplatelet Therapy in Elderly Patients

 Courtesy of the SBHCI. This study sought to assess the safety and efficacy of an everolimus-eluting stent with...
solaci -
Acute coronary syndromes

TCT 2017 | REDUCE: 3 vs 12 Months of Dual Antiplatelet Therapy with the New Combo DES

Courtesy of SBHCI. This new device has, on one hand, an abluminal sirolimus coating, and on the other...
solaci -